slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 43,771-43,800
Pages 10,126
Rows per page 30
Component
43,771-43,800 of 303,780
47
Includes a biological pathway diagram showing LSD1 interactions with various complexes and substrates.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
48
Includes a biological pathway diagram and supporting bullet points on therapeutic mechanism and safety profile.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
49
The slide uses a process flow diagram to explain the therapeutic mechanism and competitive advantage of the '539 molecule.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
50
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
51
The slide uses a three-column layout to define the technical requirements for the drug candidate.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
52
The slide uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
53
The slide uses a linear process flow to explain a complex drug discovery pipeline.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
54
The chart illustrates a Pareto front in drug discovery, highlighting that the 'best' molecules (on the front) are not always the most information-rich for further development.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
55
The slide uses two distinct chart types (dot plot and line chart with error bars) to demonstrate safety advantages.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
56
Includes box plots for overall differentiation and line plots for patient-specific heterogeneity categorized by differentiation level.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
57
The slide uses a heatmap to visualize synergy (green) vs no synergy (light green) across 6 different drug combinations.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
58
The slide shows two charts: a line chart for tumour volume over time and a dot plot for plasma pro-GRP concentration. Statistical significance markers are present.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
59
Includes a heatmap showing synergy scores across cell lines and two dose-response line charts showing increased inhibition in combination.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
60
The heatmap displays AUC (Response) values across 16 patient samples for three different treatments.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
61
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
62
MIDD = Model-informed Drug DevelopmentExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
63
The slide uses a stylized molecular visualization as a background element.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
64
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
65
Scientific diagram showing the BCR and TLR signaling pathways converging on MALT1 and NF-kB.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
66
The slide uses a three-column layout to define the core pillars of the drug development strategy.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
67
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
68
The slide uses a heatmap-style table to visualize performance against criteria, with a specific callout box around the UGT1A1 row.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
69
The slide outlines a multi-stage pipeline: Initiate, Analyse, Evolve, 2D Models, 3D Models, and Active Learning.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
70
The slide highlights the technical methodology behind the 565 candidate development, specifically focusing on allosteric site constraints and permeability.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
71
The slide demonstrates efficacy and synergy in vivo for a drug candidate ('565) in DLBCL models.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
72
The slide uses two dose-response curves to demonstrate selectivity.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
73
The table uses a heatmap-style color coding (red/green) to indicate risk levels for UGT1A1 inhibition parameters.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
74
The slide uses a two-column layout to contrast PK data with Toxicology/Safety data.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
75
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
04
Exscientia | Results Presentation Deck | 24 slidesExscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain2 hits